SCHEMBL2960975

SCHEMBL2960975

COC(=O)C1CC2C=CC1O2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM3 P20309 1/20 0.34
PPM1B O75688 1/20 0.33
PTPN1 P18031 1/20 0.33
PPP1CC P36873 1/20 0.33
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CYP2C19 P33261 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23264992 1.00 CYP1A2 (0.35) CYP1A2HSD17B10CYP3A4CYP2D6TSHR
SCHEMBL11907921 0.82 ALDH1A1 (0.33) CYP1A2CYP2C19
SCHEMBL11907446 0.82
SCHEMBL5718171 0.81 PPM1B (0.38) HSD17B10TSHRPPM1BPTPN1PPP1CC
SCHEMBL8836695 0.81 PPM1B (0.38) HSD17B10TSHRPPM1BPTPN1PPP1CC
SCHEMBL4381215 0.81 MAPK1 (0.33) MAPK1
SCHEMBL4384510 0.81 POLB (0.33)
SCHEMBL8102462 0.81 PPM1B (0.38) HSD17B10TSHRPPM1BPTPN1PPP1CC
SCHEMBL4386205 0.81 PPM1B (0.38) HSD17B10TSHRPPM1BPTPN1PPP1CC
SCHEMBL17662660 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120004913-A High-purity synthesis method of 5-oxo hexahydro-2, 6-methylfuro [3,2-B ] furan-3-yl methacrylate 成都东凯芯半导体材料有限公司 2025-05-16 CN claimed
CN-120004913-A High-purity synthesis method of 5-oxo hexahydro-2, 6-methylfuro [3,2-B ] furan-3-yl methacrylate 成都东凯芯半导体材料有限公司 2025-05-16 CN disclosed
US-11932616-B2 Diels-Alder ring-opening process NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2024-03-19 US disclosed
EP-3788030-B1 DIELS- ALDER RING-OPENING PROCESS TNO (NL) 2023-06-07 EP disclosed
US-20230132653-A1 MOLECULAR RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-04 US disclosed
US-20210115005-A1 DIELS-ALDER RING-OPENING PROCESS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2021-04-22 US disclosed
EP-3788030-A1 DIELS- ALDER RING-OPENING PROCESS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2021-03-10 EP disclosed
US-10866230-B2 Fiber coated nanopores TRUSTEES OF BOSTON UNIVERSITY (US) 2020-12-15 US disclosed
US-20190300645-A1 NEW HYDROCARBON POLYMERS WITH EXO-VINYLENE CYCLOCARBONATE END GROUPS BOSTIK SA (FR) 2019-10-03 US disclosed
US-20190241700-A1 HYDROCARBON POLYMERS HAVING TWO 2-OXO-1,3-DIOXOLANE-4-CARBOXYLATE END GROUPS BOSTIK SA (FR) 2019-08-08 US disclosed
US-20030050398-A1 Novel epoxy compounds having an alicyclic structure, polymer compounds, resist materials, and patterning methods SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-03-13 US disclosed
EP-1245569-A1 PROCESS FOR THE PRODUCTION OF 5-OXY-7-OXABICYCLO- 4.1.0]HEPT-3-E NE-3-CARBOXYLIC ACID ESTERS SAGAMI CHEMICAL RESEARCH CENTER (JP) 2002-10-02 EP disclosed
US-20020102493-A1 Polymer, resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-08-01 US disclosed
US-6372854-B1 POLYALKENAMERS USED AS PHOTORESISTS HAVING EXCELLENT OPTICAL ELECTRICAL PROPERTIES; HIGH RIGIDITY; HEAT RESISTANCE; ADHESION AND WEAR RESISTANCE; HYDROGENATION; ACIDOLYSIS MITSUI CHEMICALS, INC. (JP) 2002-04-16 US disclosed
EP-0104583-B1 PROCESS FOR THE PREPARATION OF 7-OXABICYCLO(2.2.1)HEPT-5-ENE DERIVATIVES Chemische Fabrik Stockhausen GmbH (DE) 1989-09-06 EP disclosed
EP-0104584-B1 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED ACRYLAMIDE Chemische Fabrik Stockhausen GmbH (DE) 1986-09-03 EP disclosed
US-4605740-A Process for the production of N-substituted acrylic acid amides CHEMISCHE FABRIK STOCKHAUSEN GMBH (DE) 1986-08-12 US disclosed
US-4555581-A Process for the production of 7-oxabicyclo (2.2.1)hept-5-ene derivatives CHEMISCHE FABRIK STOCKHAUSEN GMBH (DE) 1985-11-26 US disclosed
EP-0104584-A1 Process for the preparation of N-substituted acrylamide Chemische Fabrik Stockhausen GmbH (DE) 1984-04-04 EP disclosed
EP-0104583-A2 Process for the preparation of 7-oxabicyclo(2.2.1)hept-5-ene derivatives Chemische Fabrik Stockhausen GmbH (DE) 1984-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115005-A1 DIELS-ALDER RING-OPENING PROCESS SQLE, GFER, OXER1 CYP1A2 96/4885HSD17B10 575/4885CYP3A4 81/4885
US-11932616-B2 Diels-Alder ring-opening process SQLE, GFER, OXER1 CYP1A2 96/4885HSD17B10 575/4885CYP3A4 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.